Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-85
Closed -$1K 94
2016
Q2
$1K Sell
85
-594,917
-100% -$7.06M ﹤0.01% 553
2016
Q1
$7.64M Sell
595,002
-38,457
-6% -$460K 0.29% 124
2015
Q4
$7.81M Buy
633,459
+184,228
+41% +$2.36M 0.24% 147
2015
Q3
$5.47M Buy
449,231
+145,068
+48% +$1.96M 0.25% 127
2015
Q2
$4.34M Buy
304,163
+110,153
+57% +$1.74M 0.09% 256
2015
Q1
$2.7M Buy
194,010
+26,060
+16% +$390K 0.05% 256
2014
Q4
$2.76M Buy
167,950
+4,200
+3% +$72.1K 0.03% 351
2014
Q3
$2.89M Sell
163,750
-1,800
-1% -$35.3K 0.02% 459
2014
Q2
$3.25M Sell
165,550
-59,250
-26% -$1.24M 0.02% 435
2014
Q1
$5.15M Buy
+224,800
New +$5.01M 0.04% 312

Other funds holding CCJ

Euclid Advisors's CCJ Position: Q3 2016 in Review

Euclid Advisors sold out of Cameco (CCJ) in Q3 2016, closing a stake of 85 shares — an estimated $1K sold.

Euclid Advisors first reported a position in CCJ in Q1 2014 and held it in 10 quarters. The position peaked at $7.81M in Q4 2015. 238 funds tracked by Wall St. Rank hold CCJ as of Q3 2016.

  • Euclid Advisors reported no remaining Cameco position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 85 Cameco shares in Q3 2016, an estimated $1K.
  • Euclid Advisors first reported a position in Cameco in Q1 2014 and held it in 10 quarters.
  • Euclid Advisors's Cameco position peaked at $7.81M in Q4 2015.
  • 238 funds tracked by Wall St. Rank held Cameco as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.